Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ResMed Inc. has announced the appointment of Christopher DelOrefice as a new board member, effective until the company’s annual meeting of stockholders on November 21, 2024. DelOrefice, with extensive financial experience at Becton Dickinson and Johnson & Johnson, will also join the audit committee. This strategic appointment aims to strengthen ResMed’s leadership and governance.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- Ford Mustang Cobra Jet Fastest Electric Car on the Planet, Ford Stock (NYSE:F) Notches Up
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test